Schedule 13G ownership disclosure
ArriVent Biopharma Inc
COMMON STOCK · CUSIP: 04272N102
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 2,863,340.21 · Class: 5.8%
- Abigail P. Johnson
Shares: 2,863,340.21 · Class: 5.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-26-002691
- Form type
- SCHEDULE 13G/A
- Filer
- ArriVent BioPharma, Inc.
- CIK
- CIK 1868279
- Filed
- Nov 05, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership